Internationalvaccineinstitute

05/10/2019

IVI scientists’ paper recommended by Faculty of 1000 Biology, and Korea’s bioscience portal

Dr. Manki Song, Acting Deputy Director General of Science   Dr. Manki Song, Acting Deputy Director General of Science, Dr. Jae Seung Yang, Senior Scientist, and Ms. Eun Young Lee, Researcher at IVI, and others’ manuscript “Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, […]
05/15/2019

Former KSC Vice President Ms. Joanne Lee donates 50 million KRW to IVI

  Ms. Joanne Lee, former Vice President of the Korea Support Committee for IVI and former Chairperson of the IVI Fundraising Campaign Committee (2005-2006), donated 50 million KRW (US$42,000) via KSC to support IVI’s vaccine research and development. Ms. Lee, who is currently based in […]
05/16/2019

IVI welcomes China National Biotec Group Company Limited (CNBG) delegation

  On May 16, 2019, IVI was honored to receive a delegation from China National Biotec Group Company Limited (CNBG), China’s biggest vaccine manufacturer. Led by its President, Mr. WU Yonglin, CNBG and IVI discussed possibilities for collaborating to increase the impact of CNBG’s vaccines […]
05/21/2019

IVI thanks Rotarians for support at annual convention

  On May 17, IVI’s COO, Francois Belin addressed members of Rotary International District 3640 at their annual Convention in Seoul, Korea and thanked them for their important contributions. IVI’s partnership with Rotary 3640 began back in 2016 with the signing of an MOU which […]